These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18675061)

  • 1. Evidence of liver histological alterations in apparently healthy individuals evaluated for living donor liver transplantation.
    Cuomo O; Perrella A; Pisaniello D; Marino G; Di Costanzo G
    Transplant Proc; 2008; 40(6):1823-6. PubMed ID: 18675061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
    J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
    Ryan CK; Johnson LA; Germin BI; Marcos A
    Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits.
    Nadalin S; Malagó M; Valentin-Gamazo C; Testa G; Baba HA; Liu C; Frühauf NR; Schaffer R; Gerken G; Frilling A; Broelsch CE
    Liver Transpl; 2005 Aug; 11(8):980-6. PubMed ID: 16035060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index as a predictor of hepatic steatosis in living liver donors.
    Rinella ME; Alonso E; Rao S; Whitington P; Fryer J; Abecassis M; Superina R; Flamm SL; Blei AT
    Liver Transpl; 2001 May; 7(5):409-14. PubMed ID: 11349260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors.
    Savas N; Coskun M; Bilezikci B; Uruc I; Karakayali H; Yilmaz U; Haberal M
    Liver Transpl; 2008 Apr; 14(4):541-6. PubMed ID: 18383083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
    Perkins JD
    Liver Transpl; 2006 Jun; 12(6):1012-3. PubMed ID: 16721781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
    Yamamoto K; Takada Y; Fujimoto Y; Haga H; Oike F; Kobayashi N; Tanaka K
    Transplantation; 2007 Feb; 83(3):257-62. PubMed ID: 17297396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of donors for living donor liver transplantation in a single center of a developing country: lessons learned from the first 100 cases.
    Pacheco-Moreira LF; Enne M; Balbi E; Halpern M; Peixoto A; Cerqueira A; Moreira E; Araujo C; Pereira JL; Martinho JM
    Pediatr Transplant; 2006 May; 10(3):311-5. PubMed ID: 16677354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
    Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
    Transpl Int; 2006 Oct; 19(10):807-13. PubMed ID: 16961772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
    Jun MJ; Shim JH; Kim SY; Seo N; Kim KM; Lim YS; Lee HC; Yu E; Lee SG
    Liver Transpl; 2014 Apr; 20(4):437-45. PubMed ID: 24478019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic artery-portal vein fistula formation after percutaneous liver biopsy in a living liver donor.
    Gabriel S; Maroney TP; Ringe BH
    Transplant Proc; 2007 Jun; 39(5):1707-9. PubMed ID: 17580227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation for Dorfman-Chanarin syndrome with 1 year follow-up: case report.
    Takeda K; Tanaka K; Kumamoto T; Morioka D; Endo I; Togo S; Shimada H
    Transplant Proc; 2010 Nov; 42(9):3858-61. PubMed ID: 21094870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of detailed preoperative evaluation on donors in right lobe living donor liver transplantation.
    Zhang Y; Wen T; Yan L; Chen Z; Li B; Zeng Y; Zhao J; Wang W; Yang J; Xu M; Ma Y
    Hepatogastroenterology; 2008; 55(86-87):1725-8. PubMed ID: 19102378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for acute liver failure: a single center experience.
    Cariús LP; Pacheco-Moreira LF; Balbi E; Leal CR; Gonzalez AC; Agoglia LV; Araújo C; Enne M; Martinho JM
    Transplant Proc; 2009 Apr; 41(3):895-7. PubMed ID: 19376382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of hepatic progenitor cell in fatty liver graft after living donor liver transplantation.
    Cho JY; Suh KS; Shin WY; Lee HW; Yi NJ; Kim MA; Jang JJ; Lee KU
    Transpl Int; 2010 May; 23(5):530-7. PubMed ID: 20003044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal number of donor biopsy sites to evaluate liver histology for transplantation.
    Frankel WL; Tranovich JG; Salter L; Bumgardner G; Baker P
    Liver Transpl; 2002 Nov; 8(11):1044-50. PubMed ID: 12424718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.